N-[5-methyl-4-[7-[(2-morpholinoacetyl)amino]-1H-indol-3-yl]pyrimidin-2-yl]cyclopropanecarboxamide

ID: ALA4476801

PubChem CID: 155538485

Max Phase: Preclinical

Molecular Formula: C23H26N6O3

Molecular Weight: 434.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cnc(NC(=O)C2CC2)nc1-c1c[nH]c2c(NC(=O)CN3CCOCC3)cccc12

Standard InChI:  InChI=1S/C23H26N6O3/c1-14-11-25-23(28-22(31)15-5-6-15)27-20(14)17-12-24-21-16(17)3-2-4-18(21)26-19(30)13-29-7-9-32-10-8-29/h2-4,11-12,15,24H,5-10,13H2,1H3,(H,26,30)(H,25,27,28,31)

Standard InChI Key:  ALXCGHGMHUVLDR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    2.2273  -20.8218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2261  -21.6455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9383  -22.0545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6521  -21.6450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6493  -20.8182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9365  -20.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3646  -22.0525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0716  -21.6428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9283  -19.5866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5117  -18.3262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2616  -19.1082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5154  -20.4093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3331  -18.3237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5880  -19.1044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3884  -19.2741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9347  -18.6641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6792  -17.8817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8794  -17.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6246  -16.9392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1696  -16.3303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9148  -15.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9694  -16.4979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0704  -20.8256    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7800  -22.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1912  -22.7541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5987  -22.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4598  -14.9450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2647  -15.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8088  -14.5088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5579  -13.7307    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7576  -13.5610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2081  -14.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  9 14  1  0
 13 10  1  0
 10 11  1  0
 11  9  2  0
  6  9  1  0
  1 12  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
  8 23  2  0
  8 24  1  0
 25 24  1  0
 26 25  1  0
 24 26  1  0
 21 27  1  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476801

    ---

Associated Targets(Human)

JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.50Molecular Weight (Monoisotopic): 434.2066AlogP: 2.55#Rotatable Bonds: 6
Polar Surface Area: 112.24Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.01CX Basic pKa: 5.18CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -1.71

References

1. Su Q, Banks E, Bebernitz G, Bell K, Borenstein CF, Chen H, Chuaqui CE, Deng N, Ferguson AD, Kawatkar S, Grimster NP, Ruston L, Lyne PD, Read JA, Peng X, Pei X, Fawell S, Tang Z, Throner S, Vasbinder MM, Wang H, Winter-Holt J, Woessner R, Wu A, Yang W, Zinda M, Kettle JG..  (2020)  Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor.,  63  (9): [PMID:32297743] [10.1021/acs.jmedchem.9b01392]

Source